1-3 of 3
Cathrin Theuser
Close
Sort by
Journal Articles

Treatment of High Risk AML and MDS with Ara-C-Containing Standard Chemotherapy Followed by Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation (RIC-SCT) during Aplasia: A Survey of the German Cooperative Transplant Study Group (GCTSG).

Jolanta B. Dengler, MD, Matthias Stelljes, MD, Cathrin Theuser, Ute Hegenbart, MD, Christoph Schmid, MD, Joachim Kienast, Anthony D. Ho, Gerhard Ehninger, Peter Dreger, Martin Bornhaeuser
Journal: Blood
Blood (2006) 108 (11): 5376.
https://doi.org/10.1182/blood.V108.11.5376.5376
Published: 2006
Journal Articles

Second Stem Cell Harvest from Unrelated Donors for Patients with Relapse or Graft Failure after First Transplantation: Patient Age >50 Years and Relapse of Malignant Disease Are Associated with Poor Outcome.

Uwe Platzbecker, Susanne Zapf, Cathrin Theuser, Alexander Schmidt, Claudia Rutt, Gerhard Ehninger, Martin Bornhauser
Journal: Blood
Blood (2006) 108 (11): 3107.
https://doi.org/10.1182/blood.V108.11.3107.3107
Published: 2006
Journal Articles

Impact of gamma/delta TCR + , Foxp3 + and Toll-Like Receptor Expressing T-Cells on the Outcome of Patients Receiving Unrelated Peripheral Blood Stem Cell Transplantation.

Uwe Platzbecker, Caroline Pabst, Holger Schirutschke, Ines Wagner, Cathrin Theuser, Gerhard Ehninger, Martin Bornhauser
Journal: Blood
Blood (2006) 108 (11): 2899.
https://doi.org/10.1182/blood.V108.11.2899.2899
Published: 2006